(Q39957684)

15 September 2017

title

Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells (English)

1 reference

15 September 2017

H Yang

1

1 reference

15 September 2017

J-H Fu

2

1 reference

15 September 2017

Y Hu

3

1 reference

15 September 2017

W-Z Huang

4

1 reference

15 September 2017

B Zheng

5

1 reference

15 September 2017

G Wang

6

1 reference

15 September 2017

X Zhang

7

1 reference

15 September 2017

J Wen

8

1 reference

15 September 2017

publication date

1 July 2008

1 reference

Journal of International Medical Research

15 September 2017

published in

1 reference

15 September 2017

volume

36

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

734-747

1 reference

15 September 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Tumor senescence as a determinant of drug response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Survivin gene expression in early-stage non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Overexpression of metallothionein confers resistance to anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

Mitosis-independent survivin gene expression in vivo and regulation by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600416

10.1177/147323000803600416

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference